Ascelia Pharma AB (publ) (STO:ACE)
Sweden flag Sweden · Delayed Price · Currency is SEK
4.090
-0.130 (-3.08%)
May 23, 2025, 5:29 PM CET

Ascelia Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
4752811145031,0051,590
Upgrade
Market Cap Growth
-12.68%146.68%-77.38%-49.95%-36.78%186.78%
Upgrade
Enterprise Value
444212763247161,370
Upgrade
Last Close Price
4.092.923.3714.9429.8556.40
Upgrade
PB Ratio
8.213.561.532.783.276.74
Upgrade
P/TBV Ratio
632.7312.836.594.064.018.88
Upgrade
Debt / Equity Ratio
0.470.320.010.000.010.01
Upgrade
Quick Ratio
0.951.311.984.1210.6510.21
Upgrade
Current Ratio
1.001.352.304.2910.9410.69
Upgrade
Return on Equity (ROE)
-140.96%-104.43%-85.65%-53.70%-46.30%-41.72%
Upgrade
Return on Assets (ROA)
-41.69%-37.35%-45.59%-33.44%-29.27%-23.06%
Upgrade
Return on Capital (ROIC)
-53.78%-47.38%-54.28%-37.61%-31.49%-24.54%
Upgrade
Earnings Yield
-17.93%-28.52%-96.07%-26.09%-12.53%-6.21%
Upgrade
FCF Yield
--22.39%-111.45%-24.90%-11.60%-5.41%
Upgrade
Buyback Yield / Dilution
-104.37%-60.15%3.10%-5.58%-25.46%-20.52%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.